文献速递颈动脉与弓上血管

无症状性颈动脉狭窄的最佳管理:系统评价与网状Meta分析

Optimal Management of Asymptomatic Carotid Artery Stenosis: A Systematic Review and Network Meta-Analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2023-01-20

该系统评价与网状Meta分析纳入17篇报告共14310例狭窄>50%的无症状性颈动脉狭窄患者,比较颈动脉内膜切除术、颈动脉支架置入术与最佳药物治疗的卒中和死亡风险;现代最佳药物治疗在主要卒中、联合卒中及死亡率上与颈动脉内膜切除术相似,但数据不足以评估可从干预中获益的亚组。

要点

  • 颈动脉内膜切除术较颈动脉支架置入术降低围手术期卒中事件风险(OR 1.6,95%CI 1.1-2.2)。
  • 颈动脉内膜切除术和支架置入术较所有最佳药物治疗降低长期轻度卒中和同侧卒中风险。
  • 现代最佳药物治疗在主要卒中、联合卒中及死亡率上与颈动脉内膜切除术相似。

核心结论

  • 现代最佳药物治疗在主要卒中、联合卒中及死亡率上显示出与颈动脉内膜切除术相似的降低。
  • 总体风险降低幅度低,且缺乏数据评估可能从干预中获益的亚组。
  • 最佳药物治疗有可能减少无症状性颈动脉狭窄患者对手术干预的需求。

研究设计与样本

  • 系统评价与一系列网状Meta分析,评估无症状性颈动脉狭窄干预的围手术期(30天内)和长期(30天至5年)卒中和死亡风险。
  • 纳入17篇报告,共14310例狭窄>50%的无症状性颈动脉狭窄患者。
  • 分别评估总卒中、主要、轻度、同侧和对侧卒中亚型,并比较传统(2000年前)与现代(2000年后)最佳药物治疗。

主要发现

  • 颈动脉内膜切除术较颈动脉支架置入术降低围手术期卒中事件几率(OR 1.6,95%CI 1.1-2.2,每1000例减少0-20例)。
  • 颈动脉内膜切除术和颈动脉支架置入术较所有最佳药物治疗降低长期轻度卒中几率(OR 0.35,95%CI 0.21-0.59,每1000例减少20例)和同侧卒中几率(OR 0.27,95%CI 0.19-0.39,每1000例减少30例)。
  • 颈动脉内膜切除术较传统最佳药物治疗降低主要卒中和联合卒中及死亡几率,但颈动脉内膜切除术与现代最佳药物治疗之间无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 总体风险降低幅度低。
  • 缺乏数据评估可能从干预中获益的亚组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Management of asymptomatic carotid artery stenosis (ACAS), including carotid endarterectomy (CEA), carotid artery stenting (CAS), and best medical treatment (BMT), remains inconsistent in current practice. Early studies reported a benefit of CEA vs. BMT; however, the current risk-benefit profile of invasive therapy lacks consensus. By evaluating the effects of modern BMT vs. invasive intervention on patient outcomes, this study aimed to influence the future management of ACAS. METHODS: A systematic review and series of network meta-analyses were performed assessing peri-operative (within 30 days) and long term (30 days - 5 years) stroke and mortality risk between ACAS interventions. Total stroke, major, minor, ipsilateral, and contralateral stroke subtypes were assessed independently. Traditional (pre-2000) and modern (post-2000) BMT were compared to assess clinical improvements in medical therapy over the previous two decades. Risks of myocardial infarction (MI) and cranial nerve injury (CNI) were also assessed. RESULTS: Seventeen reports of 14 310 patients with > 50% ACAS were included. CEA reduced the odds of a peri-operative stroke event occurring vs. CAS (odds ratio [OR] 1.6, 95% confidence interval [CI] 1.1 - 2.2 [0 - 20 fewer/1 000]). CEA and CAS reduced the long term odds of minor strokes (OR 0.35, 95% CI 0.21 - 0.59 [20 fewer/1 000]) and ipsilateral strokes (OR 0.27, 95% CI 0.19 - 0.39 [30 fewer/1 000]) vs. all BMT. CEA reduced the odds of major strokes and combined stroke and mortality vs. traditional BMT; however, no difference was found between CEA and modern BMT. CAS reduced the odds of peri-operative MI (OR 0.49, 95% CI 0. 26 - 0.91) and CNI (OR 0.07, 95% CI 0.01 - 0.42) vs. CEA. CONCLUSION: Modern BMT demonstrates similar reductions in major stroke, combined stroke, and mortality to CEA. The overall risk reductions are low and data were unavailable to assess subgroups which may benefit from intervention. However, BMT carries the potential to reduce the requirement for surgical intervention in patients with ACAS.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Gasior SA, O'Donnell JPM, Davey M, et al. Optimal Management of Asymptomatic Carotid Artery Stenosis: A Systematic Review and Network Meta-Analysis. Eur J Vasc Endovasc Surg. 2023. PMID: 36682406. doi:10.1016/j.ejvs.2023.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。